Trial intelligence / Profile preview

Lianhua Qingwen capsule for treatment of H1N1 influenza

ChiCTR-TRC-09000589Phase 4Completed

Sponsor
Beijing YouAn Hospital
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in influenza A virus infection (H1N1) comparing Lianhua Qingwen arm with Tamiflu control arm (2 arms). Primary endpoint: Time to relief of flu-like symptom. Started Oct 2009; status: completed.

02

Drugs

Lianhua Qingwenoseltamivir
03

Conditions

influenza A virus infection (H1N1)

Beyond the preview

Go deeper on ChiCTR-TRC-09000589.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-09000589.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call